Role of Signaling Transduction Pathways in Development of Castration-Resistant Prostate Cancer
Joint Authors
Source
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-10-05
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Almost all patients who succumb to prostate cancer die of metastatic castration-resistant disease.
Although docetaxel is the standard treatment for this disease and is associated with modest prolongation of survival, there is an urgent need for novel treatments for castration-resistant prostate cancer (CRPC).
Great advances in our understanding of the biological and molecular mechanisms of prostate cancer progression have resulted in many clinical trials of numerous targeted therapies.
In this paper, we review mechanisms of CRPC development, with particular focus on recent advances in the understanding of specific intracellular signaling pathways participating in the proliferation of CRPC cells.
American Psychological Association (APA)
Inoue, Takahiro& Ogawa, Osamu. 2011. Role of Signaling Transduction Pathways in Development of Castration-Resistant Prostate Cancer. Prostate Cancer،Vol. 2011, no. 2011, pp.1-7.
https://search.emarefa.net/detail/BIM-487987
Modern Language Association (MLA)
Inoue, Takahiro& Ogawa, Osamu. Role of Signaling Transduction Pathways in Development of Castration-Resistant Prostate Cancer. Prostate Cancer No. 2011 (2011), pp.1-7.
https://search.emarefa.net/detail/BIM-487987
American Medical Association (AMA)
Inoue, Takahiro& Ogawa, Osamu. Role of Signaling Transduction Pathways in Development of Castration-Resistant Prostate Cancer. Prostate Cancer. 2011. Vol. 2011, no. 2011, pp.1-7.
https://search.emarefa.net/detail/BIM-487987
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-487987